1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Toxin-Based Rodent Models of Parkinson’s Disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2019
-
Mark
The amphetamine induced rotation test : A re-assessment of its use as a tool to monitor motor impairment and functional recovery in rodent models of Parkinson's disease
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
-
Mark
Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2014
-
Mark
Preclinical models of levodopa-induced dyskinesia
2014) p.335-353(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2012
-
Mark
CELL REPLACEMENT THERAPY FOR PARKINSON’S DISEASE: The importance of neuronal subtype, cell source and connectivity for functional recovery
(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2005
-
Mark
Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease
(
- Contribution to journal › Article
- 2004
-
Mark
Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article